Literature DB >> 2176687

Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.

S A Ballard1, S L Kelly, S W Ellis, P F Troke.   

Abstract

A simple procedure has been developed for isolating a microsomal fraction from Aspergillus fumigatus which contains cytochrome P-450. Maximum absorbance of the carbon monoxide/ferrous cytochrome P-450 difference spectrum was at a wavelength of 451 nm. The triazole antifungal agents, fluconazole and itraconazole, produced type II binding difference spectra with ferric cytochrome P-450 in A. fumigatus microsomes and an azole concentration of 0.5 microM was sufficient to saturate the spectroscopic response when the cytochrome P-450 concentration was 0.07 microM. This extremely high affinity binding precluded the determination of apparent dissociation constants for the cytochrome P-450-azole complexes. Itraconazole was found to have a marginally greater affinity for cytochrome P-450 than fluconazole, as determined from a comparison of their potential to reduce the rate of binding of carbon monoxide to the ferrous haemoprotein. The high affinity binding of both compounds to the cytochrome P-450 from A. fumigatus is consistent with their proposed antifungal mode of action through inhibition of the sterol 14 alpha-demethylase cytochrome P-450 required for ergosterol biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176687

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  9 in total

1.  Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.

Authors:  K Venkateswarlu; D W Denning; N J Manning; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.

Authors:  R C Hahn; J S Hamdan
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.

Authors:  Claire M Martel; Josie E Parker; Andrew G S Warrilow; Nicola J Rolley; Steven L Kelly; Diane E Kelly
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae.

Authors:  Andrew S Chau; Guodong Chen; Paul M McNicholas; Paul A Mann
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Optimization of the benzoate-inducible benzoate p-hydroxylase cytochrome P450 enzyme system in Aspergillus niger.

Authors:  J M van den Brink; C A van den Hondel; R F van Gorcom
Journal:  Appl Microbiol Biotechnol       Date:  1996-11       Impact factor: 4.813

6.  Study on the hyphal responses of Aspergillus fumigatus to the antifungal agent by Bio-Cell Tracer.

Authors:  L Ansheng; H Taguchi; M Miyaji; K Nishimura; S Wu
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

7.  Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance.

Authors:  K Venkateswarlu; D W Denning; N J Manning; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

8.  Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.

Authors:  Andrew G S Warrilow; Nadja Melo; Claire M Martel; Josie E Parker; W David Nes; Steven L Kelly; Diane E Kelly
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

9.  Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus.

Authors:  P David Rogers; Jarrod R Fortwendel; Jeffrey M Rybak; Wenbo Ge; Nathan P Wiederhold; Josie E Parker; Steven L Kelly
Journal:  mBio       Date:  2019-04-02       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.